CTMX vs JNJ: Which Stock is Better?
Side-by-side comparison of CytomX Therapeutics Inc and Johnson & Johnson in 2026
CTMX
CytomX Therapeutics Inc
—
JNJ
Johnson & Johnson
$248.82
Key Metrics Comparison
| Metric | CTMX | JNJ | Winner |
|---|---|---|---|
| Market Cap | $653.11M | $375.37B | JNJ |
| P/E Ratio | N/A | 17.35 | JNJ |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze CTMX
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CTMX or JNJ a better investment?
Comparing CTMX and JNJ: CytomX Therapeutics Inc has a market cap of $653.11M while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CTMX and JNJ?
CTMX (CytomX Therapeutics Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CTMX or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CTMX or JNJ?
Both CTMX and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: CTMX or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: CTMX or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $653.11M for CTMX.
Should I buy CTMX or JNJ in 2026?
Both CTMX and JNJ have investment merit. CTMX trades at $N/A while JNJ trades at $248.82. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CTMX and JNJ stock?
Key differences: Market Cap ($653.11M vs $375.37B), P/E Ratio (N/A vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy CTMX or JNJ in 2026?
The choice between CTMX and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CTMX and JNJ?
CTMX (CytomX Therapeutics Inc) has a market cap of $653.11M, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.